Screener
Trevi Therapeutics, Inc. TRVI Exercised (in shares)
Exercised (in shares) at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.
The source filing: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206390
| Line item | Number of Option Shares | Weighted Average Exercise Price |
|---|---|---|
| Outstanding as of December 31, 2025 | 9,301,618 | $3.63 |
| Granted | 3,176,250 | $10.66 |
| Exercised | (104,992) | $2.11 |
| Forfeited | (331,190) | $6.74 |
| Expired | — | — |
| Outstanding as of March 31, 2026 | 12,041,686 | $5.41 |
| Options exercisable as of March 31, 2026 | 5,918,559 | $3.46 |
| Options unvested as of March 31, 2026 | 6,123,127 | $7.29 |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is Trevi Therapeutics, Inc.'s exercised (in shares)?
- Trevi Therapeutics, Inc. (TRVI) reported exercised (in shares) of $2.11 in Q1 2026.
- How has Trevi Therapeutics, Inc.'s exercised (in shares) changed year-over-year?
- Trevi Therapeutics, Inc.'s exercised (in shares) decreased by 14.6% year-over-year, from $2.47 to $2.11.
- What does exercised (in shares) mean?
- The weighted average exercise price at which employees and directors exercised their stock options during the period. This provides insight into the historical price levels at which equity incentives were realized by participants.
Ask your AI about Trevi Therapeutics, Inc.'s exercised (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude